Edit |   |
---|---|
Product Name | A77 1726 |
Description | A77 1726 is a small molecule which can act as a DHODH inhibitor. It is provided as a powder. This product acts on the following target types: Dehydrogenase (GAPDH, GPDH, IMPDH, PHGDH, LDH, DHODH, ALDH, GDH, IDH, UGDH, DPD, DHPDH, and MDH). This product acts on the following biochemical pathways: Nucleoside biosynthesis, Transcription, NFkappaB. This product may be of interest in the following research areas and diseases: Immunology, Inflammation, Infectious disease. This product may act as a Coronavirus inhibitor: Inhibits Sars-CoV-2 in cells, possibly through UTP depletion. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 270.21 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | A77 1726, 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide, Teriflunomide, 108605-62-5 |
Gene, Accession, CAS # | CAS: 108605-62-5 |
Catalog # | abx282325 |
Price | please inquire |
Order / More Info | A77 1726 from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950